Literature DB >> 15117952

Crystal structure of hormone-bound atrial natriuretic peptide receptor extracellular domain: rotation mechanism for transmembrane signal transduction.

Haruo Ogawa1, Yue Qiu, Craig M Ogata, Kunio S Misono.   

Abstract

A cardiac hormone, atrial natriuretic peptide (ANP), plays a major role in blood pressure and volume regulation. ANP activities are mediated by a single span transmembrane receptor carrying intrinsic guanylate cyclase activity. ANP binding to its extracellular domain stimulates guanylate cyclase activity by an as yet unknown mechanism. Here we report the crystal structure of dimerized extracellular hormone-binding domain in complex with ANP. The structural comparison with the unliganded receptor reveals that hormone binding causes the two receptor monomers to undergo an intermolecular twist with little intramolecular conformational change. This motion produces a Ferris wheel-like translocation of two juxtamembrane domains in the dimer with essentially no change in the interdomain distance. This movement alters the relative orientation of the two domains by a shift equivalent to counterclockwise rotation of each by 24 degrees. These results suggest that transmembrane signaling by the ANP receptor is initiated via a hormone-induced rotation mechanism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117952     DOI: 10.1074/jbc.M313222200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Ca(2+) sensor GCAP1: A constitutive element of the ONE-GC-modulated odorant signal transduction pathway.

Authors:  Alexandre Pertzev; Teresa Duda; Rameshwar K Sharma
Journal:  Biochemistry       Date:  2010-08-31       Impact factor: 3.162

Review 2.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

Review 3.  Atrial natriuretic factor-receptor guanylate cyclase signal transduction mechanism.

Authors:  Teresa Duda
Journal:  Mol Cell Biochem       Date:  2009-11-26       Impact factor: 3.396

Review 4.  Membrane guanylate cyclase is a beautiful signal transduction machine: overview.

Authors:  Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2009-12-03       Impact factor: 3.396

5.  A functional kinase homology domain is essential for the activity of photoreceptor guanylate cyclase 1.

Authors:  Grzegorz Bereta; Benlian Wang; Philip D Kiser; Wolfgang Baehr; Geeng-Fu Jang; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2009-11-09       Impact factor: 5.157

6.  Allosteric modification, the primary ATP activation mechanism of atrial natriuretic factor receptor guanylate cyclase.

Authors:  Teresa Duda; Prem Yadav; Rameshwar K Sharma
Journal:  Biochemistry       Date:  2011-01-26       Impact factor: 3.162

Review 7.  Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase.

Authors:  Kunio S Misono; John S Philo; Tsutomu Arakawa; Craig M Ogata; Yue Qiu; Haruo Ogawa; Howard S Young
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

Review 8.  Privileged frameworks from snake venom.

Authors:  T A Reeks; B G Fry; P F Alewood
Journal:  Cell Mol Life Sci       Date:  2015-02-19       Impact factor: 9.261

9.  Homologous desensitization of guanylyl cyclase A, the receptor for atrial natriuretic peptide, is associated with a complex phosphorylation pattern.

Authors:  Juliane Schröter; René P Zahedi; Michael Hartmann; Birgit Gassner; Alexandra Gazinski; Jens Waschke; Albert Sickmann; Michaela Kuhn
Journal:  FEBS J       Date:  2010-04-26       Impact factor: 5.542

10.  Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.

Authors:  Candace Y W Lee; Brenda K Huntley; Daniel J McCormick; Tomoko Ichiki; S Jeson Sangaralingham; Ondrej Lisy; John C Burnett
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2015-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.